Skingenix, Inc.
Clinical trials sponsored by Skingenix, Inc., explained in plain language.
-
New ointment shows promise for stubborn leg sores
Disease control CompletedThis study tested a wound ointment called MEBO on people with venous leg ulcers, which are slow-healing sores on the lower leg. The goal was to see if MEBO helps the ulcer heal completely within 8 weeks compared to standard care. Only 5 people took part, so results are very early…
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated May 01, 2026 22:43 UTC
-
New ointment shows promise for diabetic foot wounds
Disease control CompletedThis study tested whether a special ointment called MEBO can help heal diabetic foot ulcers better than standard treatment. About 75 adults with diabetes and foot sores that had lasted at least 4 weeks took part. Researchers measured how many ulcers fully healed and how long it t…
Phase: PHASE2 • Sponsor: Skingenix, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC